Omicron linked to multisystem long COVID and GI symptoms in veterans study
Omicron infection raises risk of multisystem long COVID for veterans
This retrospective cohort study of 1,120 veterans at a VA Medical Center found Omicron variants associated with increased multisystem long C…
Omicron variants caused more multisystem long COVID symptoms than earlier strains in a large rural veteran study group.
Mechanistic review discusses host-directed therapy for children with Long COVID and secondary bacterial pneumonia
Could monitoring specific blood markers help prevent long-term lung damage in kids with Long COVID?
This mechanistic review addresses Long COVID, Post-Acute Sequelae of SARS-CoV-2 infection, and secondary bacterial pneumonia in children.
Monitoring blood markers like ferritin and D-dimer could help doctors catch dangerous lung inflammation early in kids with Long COVID before…
Protocol for observational study of digital cognitive assessments in post-COVID-19 condition
New Tool Spots “Brain Fog” After COVID in Just 15 Minutes
This is a protocol for a single-center, cross-sectional observational study in the Luxembourgish Predi-COVID cohort.
A new digital tool spots lingering brain fog after COVID in just 15 minutes, offering a faster alternative to long clinic visits for million…
Narrative review examines pathophysiological mechanisms of post-exertional malaise in PCC and CFS
Why Your Body Crashes After Small Efforts
This narrative review synthesizes current understanding of post-exertional malaise (PEM) in individuals with Post COVID-19 Condition and Chr…
Even a short walk can trigger a dangerous crash in people with Long COVID and Chronic Fatigue Syndrome because their cells stop making energ…
Meta-analysis compares post-acute risks after SARS-CoV-2 versus other respiratory viral infections
Do You Have Post-Viral Symptoms?
This systematic review and meta-analysis of 22 studies synthesizes evidence on persistent symptoms after SARS-CoV-2 infection compared to ot…
Many post-viral symptoms like fatigue and brain fog happen after any bad virus, not just COVID, though trouble breathing and heart palpitati…
Systematic review of pediatric post-COVID-19 condition mechanisms and clinical presentations in children and adolescents
Why Some Kids Can't Shake the Effects of COVID
This systematic review examines the pediatric post-COVID-19 condition (PPCC) in children and adolescents.
Some kids still feel sick months after mild COVID due to a perfect storm of immune changes, hidden virus, and gut disruption.
Observational study examines post-acute sequelae in recovered COVID-19 patients in Long Beach
California study examines long-term symptoms in adults who recovered from COVID-19
An observational study in Long Beach, California, examined post-acute sequelae identification in adults who recovered from COVID-19.
A California study is tracking long-term health problems in adults who recovered from COVID-19, though specific results are not yet public.
COVID-like symptom prevalence studied up to 12 months after positive or negative SARS-CoV-2 tests in US adults
Study examines COVID-like symptoms in adults up to a year after testing
An observational study in US adults examined the prevalence of COVID-like symptoms up to 12 months after a positive or negative SARS-CoV-2 t…
Adults in the US reported COVID-like symptoms for up to a year after a positive or negative SARS-CoV-2 test, highlighting lingering health c…
Post-COVID-19 symptoms and conditions studied in children and adolescents in the United States
Research examines post-COVID symptoms in U.S. children and adolescents
A study of post-COVID-19 symptoms and conditions in children and adolescents in the United States was reported.
Post-COVID symptoms are being studied in U.S. children and adolescents, but no specific findings or safety details are available yet.
Phase 2 trial of Paxlovid for Long COVID cognitive, autonomic, and exercise symptoms completed
Can Paxlovid help people with Long COVID? A major trial is underway
A prospective, multi-center, double-blind, randomized, controlled Phase 2 trial enrolled 964 individuals with PASC to evaluate Paxlovid.
A major trial is testing whether Paxlovid can ease Long COVID symptoms like brain fog and severe fatigue in nearly 1,000 people.
COVID-19 survivors show brain network alterations in default mode and limbic systems
Does COVID-19 change how your brain is wired? A new map suggests it might
A systematic review and meta-analysis of 703 COVID-19 survivors and 596 healthy controls across 19 neuroimaging studies found structural and…
A new brain map shows COVID-19 survivors often have changes in the same networks used for daydreaming and emotions.
Qualitative study reveals six themes of patient experience with post-COVID-19 olfactory dysfunction
What's it really like to lose your sense of smell after COVID?
A qualitative study of 20 patients with post-COVID-19 olfactory dysfunction from a Danish otolaryngology department identified six themes de…
Losing the smell of coffee or a child's hair after COVID feels like an invisible disability that changes how people eat, socialize, and see …
Research across SARS-CoV-2 infection
Related studies from across the SARS-CoV-2 infection family.
Patients with post-COVID syndrome face significant thromboembolic risk requiring proactive monitoring and tailored anticoagulant treatments
Anticoagulant Drugs May Help Manage Thromboembolic Risks After COVID-19
This meta-analysis examines the prevalence of thromboembolic events in individuals with post-COVID syndrome. The analysis identifies a signi…
People with post-COVID syndrome may face a higher risk of blood clots, highlighting the need for proactive monitoring and tailored treatment…
E3 ubiquitin ligases modulate SARS-CoV-2 replication and immune evasion through targeted protein degradation mechanisms
SARS-CoV-2 uses host enzymes to hide from the immune system
This mini-review explores the role of E3 ubiquitin ligases in the context of SARS-CoV-2 infection. The authors synthesize how these enzymes …
New research shows how the virus hijacks specific proteins in our cells to replicate and dodge our body's natural defenses.
Casirivimab plus imdevimab reduced risk of hospitalization or death in patients with and without asthma
Trial shows antibody treatment helps COVID-19 patients with asthma
This randomized controlled trial evaluated casirivimab plus imdevimab (CAS + IMD) in outpatients with acute COVID-19. The study found that C…
A new trial shows a dual antibody treatment reduces hospitalization and death risk for COVID-19 patients, including those with asthma or ato…
Erratum issued for telehealth trends study during early COVID-19 pandemic
Erratum notice issued for a report on telehealth trends during COVID-19
An erratum notice has been published for a report on telehealth use trends during the emergence of the COVID-19 pandemic. The original study…
A correction notice clarifies that no new telehealth data exists for the early COVID-19 pandemic, so readers should consult the original rep…
Erratum issued for COVID-19 hospitalization data among health care personnel
What happened to health care workers hospitalized with COVID-19? A correction notice.
An erratum notice was published regarding data on COVID-19-associated hospitalizations among health care personnel from the COVID-NET survei…
A correction notice clarifies that a previous report on health care workers hospitalized with COVID-19 did not contain new data or findings.
Long COVID cardiovascular care should shift to mechanism-informed, subgroup-based management
Current Long COVID care relies on symptom management while future research targets specific mechanisms
This mini review synthesizes current evidence on cardiovascular Long COVID. It argues that management remains symptom-based and calls for st…
Current Long COVID care relies on symptom management while future research targets specific mechanisms for better outcomes.
Interleukin-7 therapy improves lymphocyte counts in sepsis and COVID-19 patients
Recombinant human interleukin-7 boosts white blood cells but does not save lives in sepsis or COVID-19
A meta-analysis shows recombinant IL-7 boosts lymphocytes in sepsis and COVID-19, but only reduces secondary infections in COVID-19.
A new analysis shows this drug raises low white blood cell counts in sepsis and COVID-19 but does not lower death risk or improve survival.
Review of RISE-mitigation strategies in Ghana shows high immunization coverage and improved oxygen access
Ghana reduced oxygen travel distances and improved vaccine coverage with new pandemic strategies
This review uses mixed qualitative and quantitative approaches to evaluate RISE-mitigation strategies in Ghana. The analysis covers 10 novel…
New strategies in Ghana helped get oxygen closer to patients and reached 93% of people with vaccines while treating most confirmed cases.
Narrative review on COVID-19 and gut microbiome disruption and immune effects
Microbiome disruption may link SARS-CoV-2 to long-term health issues
This narrative review synthesizes evidence on COVID-19 and the intestinal microbiome. It finds SARS-CoV-2 infection can induce dysbiosis and…
A review suggests the virus may alter gut bacteria, immune signals, and brain health, highlighting a need for One Health pandemic preparedne…
Speleotherapy improves asthma control and breathing patterns in patients with respiratory conditions
Speleotherapy improves breathing patterns and symptoms for asthma, COPD, and Long COVID patients
A randomized trial of 208 patients across Germany, Austria, and Italy found that a three-week speleotherapy course enhanced asthma control a…
A three-week course in mineral-rich caves helped people with asthma, COPD, or Long COVID breathe easier and feel better, though lung functio…
Systematic review and meta-analysis links COVID-19 infection to 41% higher new-onset diabetes risk
Meta-analysis links COVID-19 infection to higher new-onset diabetes risk
This systematic review and meta-analysis evaluated sixteen studies comparing COVID-19 survivors with non-infected individuals. The pooled an…
A meta-analysis of sixteen studies suggests COVID-19 infection is associated with a 41% increased risk of developing new-onset diabetes at l…
Systematic review finds convalescent plasma does not reduce mortality in COVID-19
Convalescent plasma does not reduce COVID-19 death risk
This systematic review of 48 RCTs (24,518 participants) found that convalescent plasma does not reduce all-cause mortality or improve clinic…
A large review of 48 trials finds convalescent plasma doesn't lower death risk in moderate to severe COVID-19. For mild cases, evidence is u…
Questions about Post-COVID-19 Condition
What conditions affect children and adolescents in the US with Post-COVID-19 symptoms?
Children and adolescents with post-COVID-19 condition commonly experience fatigue, lack of concentration, muscle pain, headache, and sleep problems, though symptoms vary and are less frequent than in adults.
Full answer →How long can COVID-like symptoms last after a positive or negative test?
COVID-like symptoms can last up to 12 months after a positive or negative test, with fatigue and brain fog being common long-term issues.
Full answer →What are the specific symptoms of Post-COVID-19 Condition in children?
Children with Post-COVID-19 Condition commonly experience fatigue, exertion intolerance, anxiety, and respiratory symptoms like cough or shortness of breath, often after mild acute illness.
Full answer →Are my long-term symptoms after SARS-CoV-2 infection more common than other viruses?
Some long-term symptoms like fatigue, brain fog, and pulmonary embolism are more common after SARS-CoV-2 than other respiratory viruses, but many symptoms appear similar across post-viral syndromes.
Full answer →Can a digital cognitive assessment study help track my Post-COVID-19 condition?
Digital cognitive assessments can help track Post-COVID-19 condition by measuring brain function and comparing results to standard tests to see if symptoms like brain fog are linked to the virus.
Full answer →